The headline is a year, paid up front
Both advertised figures are per-month rates on a twelve-month prepayment. The full year is charged at once. A reader who buys one month pays a substantially higher rate for it, on both drugs.
The problem is not that a prepayment discount exists. Several sellers here offer one. The problem is that the term is missing from the page beside the headline, so the number reads as a monthly price when it is not.
The true single-month figures are recorded on this site with their term attached, because that is the number most readers will actually be charged. Compare CoreAge Rx on those, not on the headline.
You have to walk the intake to find the real price
The one-month rate does not appear on the product pages. It becomes visible only after working through the intake to the package screen.
Once you reach that screen, the disclosure is complete: a full price ladder for both drugs, with the plan total and the per-month figure side by side. Nothing is hidden at that point.
It is in the wrong place. A price a buyer can only see after starting an intake is not a published price, which is why CoreAge Rx does not pass the price check on these boards.
It will not say who compounds the medication
CoreAge Rx does not name the pharmacy that fills a prescription. The site asks you to contact it to find out.
That is worse than a vague accreditation paragraph, because it puts the burden on the buyer to ask a question the seller could answer on the page. Direct Meds names two pharmacies with street addresses. CareBareRX names four with phone numbers.
It does name the physicians assigned in California, Massachusetts, Rhode Island and Vermont, with their license numbers. That is real disclosure at the prescriber layer. It does not substitute for the pharmacy layer, and a list covering four states is not a coverage statement.
Where it operates is not published
CoreAge Rx does not say which states it serves. It says only that restrictions are confirmed during the intake.
No published list is not the same as nationwide. Sellers that serve every state generally say so, because it is a selling point. Treat the silence as unanswered and ask directly before planning around availability.
This is the second of the seven checks CoreAge Rx fails, and unlike the pricing one it could be fixed by writing a sentence.
Charged first, reviewed after, all sales final
Payment is taken before a clinician reviews the case, and the site states that all sales are final.
Read those two sentences together. You pay, then a prescriber decides whether you are eligible, and the seller's own terms say the sale cannot be undone. Ask what happens to your money if you are declined, and get the answer in writing.
What the seller does state clearly is that there are no membership fees and no auto-rebills, and that the rate you lock in holds at every dose. So the money at risk is a single plan charge rather than a recurring one, which makes the question above the important one.
CoreAge Rx's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $99/moper month only on a 12-month prepayment of $1,188; a single month is $190, and the page carries no term beside the $99 | September 2026source |
| Tirzepatide (compounded) | $149/moper month only on a 12-month prepayment of $1,788; a single month is $239, and the page carries no term beside the $149 | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 38 providers reviewed here are paid partners today; the other 34 are not. See how this works.
See CoreAge Rx's current price →Good fit if
- Buyers who have already decided on a full year of treatment and intend to prepay it in one charge.
- Patients who expect to titrate up and want a rate that does not rise with the dose.
- People who prefer one plan charge to a medication charge with a monthly membership billed beside it.
- Readers who will complete the intake far enough to see the full price ladder before deciding anything.
Look elsewhere if
- Anyone buying month to month. The advertised figures require a twelve-month prepayment, and a single month costs substantially more on both drugs.
- Readers who need the compounding pharmacy named. CoreAge Rx asks you to contact it; Direct Meds and CareBareRX publish theirs.
- Patients who need their state confirmed before starting. No state list is published, only a promise that restrictions surface during intake.
- Anyone unwilling to pay before a clinician has reviewed their case, given that the site states all sales are final.
How this review was verified
- Read the semaglutide and tirzepatide pages at their own source URLs and logged both advertised figures with the date each was read.
- Walked the intake to the package screen, where the full ladder appears, and recorded the twelve-month plan total and the single-month rate for each drug. The walk stopped before any payment step.
- Wrote the prepayment term and the single-month rate into the qualifier on both figures, so the headline never travels without the condition that produces it.
- Left the served-states field empty rather than assuming nationwide coverage, because CoreAge Rx publishes no list and never claims all 50.
- Recorded the no-membership and no-auto-rebill statements, the charge-before-review sequence and the all-sales-final term from the seller's own pages.